Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice
Mandel, 2010
Some studies suggest GLP-1 medications may improve testosterone levels, potentially benefiting sexual health, while a 2025 analysis of US Food and Drug Administration data identified 185 reports of sexual dysfunction, particularly among men taking GLP-1 receptor agonists
Current animal studies show potential fetal risks, which is why major health organizations recommend discontinuing GLP-1 therapy three months before attempting conception
Participants who had been on the medication for 36 weeks (average weight loss of 20.9%) were then randomized to continue or switch to placebo
95% CI 2.17.9